BRPI0414611A - método de clivagem de polipeptìdeo usando variante de protease ompt - Google Patents

método de clivagem de polipeptìdeo usando variante de protease ompt

Info

Publication number
BRPI0414611A
BRPI0414611A BRPI0414611-5A BRPI0414611A BRPI0414611A BR PI0414611 A BRPI0414611 A BR PI0414611A BR PI0414611 A BRPI0414611 A BR PI0414611A BR PI0414611 A BRPI0414611 A BR PI0414611A
Authority
BR
Brazil
Prior art keywords
amino acid
polypeptide
ompt protease
cleavage method
protease variant
Prior art date
Application number
BRPI0414611-5A
Other languages
English (en)
Inventor
Kazuaki Okuno
Masayuki Yabuta
Original Assignee
Daiichi Asubio Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Asubio Pharma Co Ltd filed Critical Daiichi Asubio Pharma Co Ltd
Publication of BRPI0414611A publication Critical patent/BRPI0414611A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/585—Calcitonins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/63—Motilins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/695—Corticotropin [ACTH]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

"MéTODO DE CLIVAGEM DE POLIPEPTìDEO USANDO VARIANTE DE PROTEASE OmpT". A presente invenção refere-se a um método de clivagem de polipeptídeo caracterizado pelo fato de que arginina ou lisina está na posição P1 de um sítio de clivagem desejado em um polipeptídeo, um outro aminoácido que não ácido aspártico, ácido glutâmico ou prolina está na posição P1<39>, um aminoácido básico simples ou dois ou três aminoácidos básicos consecutivos estão localizados em qualquer local na seqüência de aminoácidos da posição P10 para a posição P3 ou da posição P3<39> para a posição P5<39>(contanto que um aminoácido básico simples não esteja localizado na posição P6 ou P4) e protease OmpT ou sua enzima variante tendo uma substituição no 97<198> aminoácido a partir do N-término é usada para clivar o sítio de clivagem desejado no polipeptídeo.
BRPI0414611-5A 2003-09-30 2004-09-29 método de clivagem de polipeptìdeo usando variante de protease ompt BRPI0414611A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003342183 2003-09-30
PCT/JP2004/014704 WO2005030956A1 (ja) 2003-09-30 2004-09-29 OmpTプロテアーゼ変異体を用いたポリペプチドの切断方法

Publications (1)

Publication Number Publication Date
BRPI0414611A true BRPI0414611A (pt) 2006-11-07

Family

ID=34386241

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0414611-5A BRPI0414611A (pt) 2003-09-30 2004-09-29 método de clivagem de polipeptìdeo usando variante de protease ompt

Country Status (12)

Country Link
US (1) US9657323B2 (pt)
EP (1) EP1674567B1 (pt)
JP (1) JP4663524B2 (pt)
KR (1) KR101099398B1 (pt)
CN (1) CN1860226B (pt)
AU (1) AU2004276687B2 (pt)
BR (1) BRPI0414611A (pt)
CA (1) CA2540446A1 (pt)
ES (1) ES2398463T3 (pt)
IL (1) IL174588A (pt)
RU (1) RU2395582C2 (pt)
WO (1) WO2005030956A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008038296A2 (en) * 2006-06-21 2008-04-03 Reliance Life Sciences Pvt Ltd Recombinant calcitonin fused to interleukin-2
WO2014058830A1 (en) 2012-10-12 2014-04-17 Sutro Biopharma, Inc. Proteolytic inactivation of select proteins in bacterial extracts for improved expression
US20220181034A1 (en) * 2018-09-19 2022-06-09 Georgia Tech Research Corporation Self-titrating bacterial protease-activated prodrug

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR79124B (pt) 1982-12-22 1984-10-02 Genentech Inc
US4784949A (en) * 1984-04-19 1988-11-15 Cetus Corporation Universal dominant selectable marker cassette
US5801038A (en) * 1984-05-29 1998-09-01 Genencor International Inc. Modified subtilisins having amino acid alterations
US5077204A (en) * 1984-06-21 1991-12-31 Chiron Corporation Yeast endopeptidase for basic amino-acid site cleavage, preparation and use
US5013653A (en) * 1987-03-20 1991-05-07 Creative Biomolecules, Inc. Product and process for introduction of a hinge region into a fusion protein to facilitate cleavage
JPH07108232B2 (ja) * 1990-10-09 1995-11-22 エム・ディ・リサーチ株式会社 ペプチド又は蛋白質の製造方法
ATE253639T1 (de) 1991-08-19 2003-11-15 Daiichi Suntory Pharma Co Ltd Verfahren zur herstellung von peptiden
DE60040771D1 (de) * 1999-03-04 2008-12-24 Asubio Pharma Co Ltd Verfahren zur kontrolle der spaltung mit ompt protease

Also Published As

Publication number Publication date
AU2004276687A1 (en) 2005-04-07
EP1674567A1 (en) 2006-06-28
JPWO2005030956A1 (ja) 2006-12-07
CN1860226A (zh) 2006-11-08
CA2540446A1 (en) 2005-04-07
IL174588A0 (en) 2006-08-20
US9657323B2 (en) 2017-05-23
EP1674567A4 (en) 2008-01-09
JP4663524B2 (ja) 2011-04-06
WO2005030956A1 (ja) 2005-04-07
RU2395582C2 (ru) 2010-07-27
RU2006114756A (ru) 2007-12-20
KR20060089724A (ko) 2006-08-09
ES2398463T3 (es) 2013-03-19
US20070077617A1 (en) 2007-04-05
IL174588A (en) 2011-07-31
EP1674567B1 (en) 2013-01-16
CN1860226B (zh) 2013-09-11
KR101099398B1 (ko) 2011-12-27
AU2004276687B2 (en) 2011-07-14

Similar Documents

Publication Publication Date Title
ES2505695T3 (es) Composiciones inmunógenas para Streptococcus pyogenes
ATE110414T1 (de) System zur bearbeitung von hefe, welches eine zur bearbeitungsstelle benachbarte negativ geladene aminosäure beeinhaltet.
BRPI0608273A2 (pt) peptìdeos para diminuição da pressão sanguìnea a partir de glicomacropeptìdeo
BR0313429A (pt) peptìdeos como excipientes solubilizantes para proteìnas do fator de crescimento beta de transformação
UY30984A1 (es) Proteinas de fusion de formula m-a para degradar péptidos beta amiloides, composiciones en base a ella, preparacion y aplicaciones.
TW200505471A (en) Casein hydrolysate, method of preparing the same, and use of the same
BR9813260A (pt) Composições de limpeza contendo variantes de protease substituìdas por multiplicação
BR9914594A (pt) Matéria protéica de digestão diminuìda e sua utilização
BR9909130A (pt) Variantes de protease de serina tendo substituições de amino-ácido
BRPI0519172A2 (pt) proteÍna mutante, polinucleotÍdeo, microorganismo transformado, e, mÉtodos de produzir uma proteÍna mutante, um peptÍdeo, e alfa-l-aspartil-l-fenilalanina-beta-Éster, e de projetar e produzir uma proteÍna mutante
ES2668967T3 (es) Inmunógenos de Escherichia coli con solubilidad mejorada
AR036196A1 (es) Agentes de contraste multimericos dirigidos a base de peptidos
BRPI0515760A (pt) proteìnas de fusão
KR960031602A (ko) 유전자 조환에 의한 사람 인슐린 전구체의 제조 및 이를 이용한 인슐린의 제조 방법
ATE168130T1 (de) Stabilisierte enzyme und waschmittelzusammensetzungen
HUP9901725A2 (hu) Szubtilizinváltozatok
BR9814760A (pt) Proteìna anticongelamento, sequência de ácido nucléico, e, produto alimentìcio.
SE0002202D0 (sv) New peptides
DE602007014210D1 (de) Prophylaktisches/therapeutisches mittel für neurodegenerative erkrankungen
DE60335726D1 (de) Chromoprotein und fluoroproteine
AR038927A1 (es) Sales de acido organico
ATE455792T1 (de) Neues phosphatbindendes protein, pharmazeutische zusammensetzungen, die dieses enthalten, und verwendung davon
BR9911891A (pt) Proteases fundidas com variantes de inibidor de subtilisina de streptomyces
BR112021016727A2 (pt) Hidrolisados de proteína com rendimento aumentado de aminoácido n-terminal
ATE447612T1 (de) Fluoreszenzproteine

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B11E Dismissal acc. art. 34 of ipl - requirements for examination incomplete
B11T Dismissal of application maintained [chapter 11.20 patent gazette]